10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Balantidium coli is a ciliated protozoan parasite known to infect the gastrointestinal tract of humans. While pigs serve as the primary reservoir host, humans can acquire the infection through the ingestion of contaminated food or water containing cysts of the parasite. Once ingested, the cysts transform into trophozoites in the colon, causing a condition known as balantidiasis. Common symptoms include diarrhea, abdominal pain, nausea, and fever. Severe cases may lead to dysentery and perforation of the intestinal wall, posing significant health risks. Diagnosis of Balantidium coli infections involves the identification of cysts or trophozoites in stool samples. Treatment typically involves antimicrobial medications, such as metronidazole or tetracycline. However, cases of resistance to these drugs have been reported, underscoring the importance of tailored treatment regimens and close medical supervision. Prevention measures focus on maintaining proper hygiene, ensuring the thorough cooking of food, and practicing safe water consumption, especially in areas with a higher prevalence of balantidiasis.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States